A method to apply a nerve inhibiting cloud surrounding a blood vessel includes creating a treatment plan, wherein the treatment plan prescribes application of the nerve inhibiting cloud towards at least a majority portion of a circumference of a blood vessel wall, and applying the nerve inhibiting cloud towards the majority portion of the circumference of the blood vessel wall for a time sufficient to inhibit a function of a nerve that surrounds the blood vessel wall.

Method and system embodiments for operating a device implantable in a subject using ultrasonic waves are described. In some embodiments, a method is performed at the implantable device to receive ultrasonic waves including an operating mode command. Then, the implantable device sets an operating mode of the implantable device to one operating mode from a plurality of predetermined operating modes based on the operating mode command.

The invention relates to reflex therapy. A method includes searching for and determining priority zones of altered receptor activity and associated muscles with impaired reflex activity, making a preliminary diagnosis of a primary zone, selecting indicator muscles and tightening a tendon of the muscle which participates in a step pattern, searching for a primary zone and determining a stimulus of a damaging modality for the primary zone, verifying the correctness of the determination of the primary zone and stimulus therefor, searching for a compensatory zone and determining a stimulus therefor, stimulating the primary zone and the compensatory receptor zone by simultaneously applying stimuli with the provocation of a deep tendon reflex. Technical result: providing accuracy in discovering zones with impaired reflex activity, determining stimuli for any type of mechanoreceptor and nociceptor damage and providing full restoration of muscle reflex activity.

Systems and methods for measuring the magnetic fields generated by renal nerves before and/or after neuromodulation therapy are disclosed herein. One method for measuring the magnetic field of target nerves during a neuromodulation procedure includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient near the target nerves, and detecting a measurement of the magnetic field generated by the target nerves. The method can further include determining, based on the measurement of the magnetic field, a location of the target nerves, a location of ablation at the target nerves, and/or a percentage the target nerves were ablated by delivered neuromodulation energy.

The disclosure relates to a computer-implemented method for monitoring diaphragmatic response to phrenic nerve stimulation. The method comprises receiving in real-time a diaphragmatic CMAP signal. The method comprises computing a baseline value of a characteristic of the CMAP signal. The characteristic represents a diaphragmatic response intensity to a phrenic nerve stimulation. The method comprises determining a threshold value of the characteristic, representing a boundary of values of the characteristic indicative of upcoming diaphragmatic palsy. The determining of the threshold value includes shifting the baseline value. The method comprises receiving in real-time a ECG signal. The method comprises repeating in real-time: detecting a QRS complex in the ECG signal, monitoring the CMAP signal, computing a real-time value of the characteristic, comparing the real-time value to the threshold value, and outputting an alert when the threshold is passed. The real-time value of the characteristic is asynchronous to the QRS complex.

A method for determining peripheral nerve stimulation during MR imaging of a patient in a MR scan unit for a MR pulse sequence is described. In the method, a plurality of model-based candidate stimulations are determined dependent on a unit vector potential of the gradient magnet field generated during MR imaging and dependent on candidate data models for different object parameter values. A model-based candidate data stimulation is selected as a stimulation model for the patient dependent on an individual patient model. A distribution of a vector potential of a gradient magnetic field acting on the patient is determined as a function of a unit gradient current for a determined position of the patient in the MR scanning unit. The nerve stimulation of the patient is determined for the determined position based on the selected candidate stimulation and a gradient current of a gradient pulse of the MR pulse sequence.

Systems and methods for enhancing diagnostic evoked potential recordings of a nerve or nerve pathway of interest. A grid array of stimulating electrodes are placed on, over, or through skin in a location beneath which a nerve or nerve pathway is suspected to lie. A stimulator controls the grid array, where each electrode is independently controllable as active or inactive, as a cathode or anode, etc. A plurality of recording electrodes may record Somato-Sensory Evoked Potentials (SSEPs) and/or Transcranial Electrical Motor Evoked Potentials (TCeMEP) in response to activation of the stimulating electrodes. A processor controls stimulating the stimulating electrodes, and receives responses from the recording electrodes, in a general search mode and a focused search mode in order to use a minimum stimulation intensity at which a maximum response amplitude is detected to continually stimulate the nerve or the nerve pathway.

A method and system for monitoring neuromuscular blockade in patients during surgical procedures. A stimulator provides stimulation to a nerve of the patient, such as train-of-four (TOF). Following such stimulation, the system and method creates a predicted recovery trend for the patient that is based upon measured recovery trend and a recovery model. The recovery model estimates a recovery trend for the patient based on initial model parameter values. The recovery model creates a predicted recovery trend that is used to estimate a recovery time for the patient. The trend values from the patient are monitored and compared to the predicted trend values throughout the operation as long as the NMT measurement is on. During recovery, the recovery model and recovery time estimates are updated based on the recovery trend being formed from measurements of the patient.

Devices and methods are described herein for treating cardiac conditions using electrical stimulation delivered to and sensing nerve activity from one or both of the AV node and nerve tissue innervating the AV node using one or more neural electrodes positioned in a location within the triangle of Koch of the right atrium.

Example systems and techniques for denervation, for example, renal denervation. In some examples, a processor determines one or more tissue characteristics of tissue proximate a target nerve and a blood vessel. The processor may generate, based on the one or more tissue characteristics, an estimated volume of influence of denervation therapy delivered by a therapy delivery device disposed within the blood vessel. The processor may generate a graphical user interface including a graphical representation of the tissue proximate the target nerve and the blood vessel and a graphical representation of the estimated volume of influence.